Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Current Market Scenario:
The global phospholipids market size reached USD 3.21 Billion in 2020 and is expected to register a significantly steady revenue CAGR during the forecast period, according to latest analysis by Emergen Research. Market growth is expected to be driven by increase in usage of phospholipids in cosmetics, food, pharmaceuticals, and other industries. Phospholipid is used in the food industry as emulsifier, flowing ingredient for chocolate, baking stabilizer, and ingredient for food instantiation and animal feed.
Drivers:
The liver, humans main detoxifying organ, can potentially benefit from Phosphatidylcholine (PC) and phospholipids in particular. PC has been proven to improve liver enzymes and indicators of Non-Alcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD), drug-induced liver damage, hepatic insulin signaling, and moreover, encourage a healthy liver. This is expected to increase demand for phospholipids, which in turn is expected to drive revenue growth of the market between 2023 and 2032. In addition, increasing need to maintain cell membrane structure is expected to propel demand going ahead.
Restraints:
Using phosphatidylcholine along with AChE inhibitors, including donepezil (Aricept) or tacrine (Cognex), can raise acetylcholine levels in the body. This can even result in cholinergic adverse effects such as seizures, muscle weakness, slow heart rate, and breathing problems. Such side effects of using phosphatidylcholine are expected to hamper market growth over the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/809
Growth Projections:
The global phospholipids market revenue is expected to expand at a CAGR of 5.3% and increase from USD 3.21 Billion in 2020 to USD 5.62 Billion in 2032. Phospholipids are important for good health because these function as a major part of cell membranes and help the body transfer and absorb needed omega-3 fats. Such factors have led to an increase in usage of phospholipids as a key ingredient in a range of foods, which is expected to boost market growth.
COVID-19 Impact Analysis:
Pharmaceutical businesses are facing difficulties caused by supply chain disruptions with the outbreak of COVID-19, which also affected pharmaceutical exports and imports. Food and beverage industries are experiencing reduced demand and disrupted distribution networks. Although at-home consumption has grown, out-of-home consumption, which has generally generated the largest margin, has decreased significantly. Long-term changes in customer behavior and reduced demand are expected to hamper revenue growth of the market to a certain extent. With demand and supply disruptions, the COVID-19 pandemic has a negative impact on the cosmetic industry, which is also impacting market growth.
Current Trends and Innovations:
Certain drugs, such as Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), can cause gastrointestinal problems like perforation, stomach problems, and gastrointestinal bleeding. PC aids in the prevention of gastrointestinal problems. Additionally, phospholipids are important component of infant formula because they contain a high concentration of fatty acids, omega-3, and omega-6. Phospholipids are gaining popularity in the infant supplement industry as a result.
Geographical Outlook:
Phospholipids market revenue from Europe is expected to expand at a significantly robust CAGR over the forecast period. Revenue growth is primarily driven by rising awareness about functional and nutritional significance of phospholipids among consumers in countries such as Germany, France, Italy, Spain, and others. In addition, increasing demand for phospholipids-based cosmetic products in such countries is expected to boost market growth.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/809
Scope of Research
| Report Details | Outcome |
| Market size in 2020 | USD 3.21 Billion |
| CAGR (2023–2032) | 5.3% |
| Revenue forecast to 2032 | USD 5.62 Billion |
| Base year for estimation | 2020 |
| Historical data | 2018–2019 |
| Forecast period | 2023–2032 |
| Quantitative units | Revenue in USD Billion and CAGR in % from 2021 to 2028 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Type, Product Type, Source, Function, Application, and Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA |
| Key companies profiled | Archer Daniels Midland Company, Cargill, Inc., Bunge Ltd., Avanti Polar Lipids, Inc., DowDuPont, Inc., Wilmar International Ltd., Berg + Schmidt GmbH & Co. KG, Lipoid GmbH, Kewpie Corporation, and Sime Darby Unimills B.V. |
| Customization scope | 10 hours of free customization and expert consultation |
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/809
Major Companies and Competitive Landscape
The global phospholipids market is fairly fragmented, with a number of large and medium-sized market players accounting for majority market revenue. Key players are deploying various strategies, entering into mergers and acquisitions, strategic agreements and contracts, developing, testing, and introducing more effective phospholipids. Some major players operating in the phospholipids market are:
- Archer Daniels Midland Company
- Cargill, Inc.
- Bunge Ltd.
- Avanti Polar Lipids, Inc.
- DowDuPont, Inc.
- Wilmar International Ltd.
- Berg + Schmidt GmbH & Co. KG
- Lipoid GmbH
- Kewpie Corporation
- Sime Darby Unimills B.V.
Strategic Development
In September 2021, Archer Daniels Midland Company, which is a leading company in animals and humans nutrition, announced its decision to acquire a 75.0% share in PetDine, Pedigree Ovens, NutraDine, and The Pound Bakery, which are leading producers of private label pet food and supplements. With the acquisition, Archer Daniels Midland Company considerably expands its pet food and supplement abilities. These Companies employs over 300 individuals and serves over 650 clients in 15 countries with a wide range of highly customized pet treat and supplement products.
In July 2020, Avanti Polar Lipids, Inc. announced the agreement to be acquired by Croda International, Plc. Avanti and Croda are teaming up to expand biosciences products, pharmaceutical services, and cGMP manufacturing capacity for biotech, pharmaceuticals, and life science research clients globally. Avanti would continue operating under the Avanti brand, with the present management team in charge. Croda's Life Sciences business will include it, as well as Croda's Health Care division.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/phospholipids-market
Emergen Research has segmented the global phospholipids on the basis of type, product type, source, function, application, and region:
- Type Outlook (Revenue, USD Billion; 2019–2032)
- Phosphatidic Acid
- Phosphatidylglycerol
- Phosphatidylethanolamine
- Phosphatidylcholine
- Phosphatidylserine
- Phosphoinositides
- Phosphatidylinositol
- Phosphatidylinositol Phosphate
- Phosphatidylinositol Bisphosphate
- Phosphatidylinositol Trisphosphate
- Product Type Outlook (Revenue, USD Billion; 2019–2032)
- Liquid
- Powder
- Particles
- Source Outlook (Revenue, USD Billion; 2019–2032)
- Natural
- Sunflower
- Soybean
- Rapeseed
- Egg
- Corn
- Canola
- Synthetic
- Natural
- Function Outlook (Revenue, USD Billion; 2019–2032)
- Texturizers
- Emulsifiers
- Stabilizers
- Releasing Agent
- Binding Agent
- Application Outlook (Revenue, USD Billion; 2019–2032)
- Pharmaceuticals
- Personal Care
- Food & Feed
- Others
- Regional Outlook (Revenue, USD Billion; 2019–2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Curated Reports You Shouldn't Miss: Dive In Now!
Teleradiology Services Market By Imaging Technique (MRI, CT, X-Rays, Ultrasound, Mammography), By End-Users (Diagnostic Centers, Hospitals & Clinics), By Products and Services (Software, Hardware, Teleradiology services), Forecasts to 2027
Biomaterials Market By Type (Ceramic, Metallic, Polymeric, Natural, Others), By Application (Cardiovascular, Ophthalmology, Orthopedic, Plastic Surgery, Neurology, Others), and Regions Forecasts to 2027
Phototherapy Devices Market By Product (LED, Fibreoptic, Conventional Phototherapy Devices), By Application (Neonatal Jaundice Management, Skin Disease Treatment), By End User (Homecare, Hospitals & Clinics), Forecasts to 2027
Healthcare Robotics Market By Type, By Application (Neurosurgery, Orthopedic Surgery, Cardiology, Laparoscopy, Pharmacy Applications, Others), By Portability (Mobile, Fixed), By End-Use Industry (Rehabilitation, Hospitals, and Others), By Region Forecasts to 2027
Biophotonics Market, By Application (Microscopy, See-through Imaging, Light Therapy, Biosensors), By Technology (In-vivo, In-vitro), By End-use (Medical Therapeutics, Medical Diagnostics, Others), By Region Forecast to 2030
Gene Editing Market, By Technology (CRISPR/Cas9, TALENS, ZFN, Restriction Enzymes, and Others), By Application (Diagnostics, Drug Discovery and Development, Cell Line, and Others), By End-use, and By Region Forecast to 2030
3D Bioprinting Market, By Component, By Application (Research Applications, Clinical Applications), By End-use (Research Organizations and Academic Institutes, Biopharmaceutical Companies), By Region Forecast to 2032
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Japanese Version: Phospholipids Market
Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights
Read our Press Release @ https://www.emergenresearch.com/press-release/global-phospholipids-market
